RETROPHIN

Welcome to the Brand page for “RETROPHIN”, which is offered here for Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy;.

Its status is currently believed to be active. Its class is unavailable. “RETROPHIN” is believed to be currently owned by “TRAVERE THERAPEUTICS, INC.”


Owner:
TRAVERE THERAPEUTICS, INC.
Owner Details
Description:
Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy;
Categories: RESEARCH DEVELOPMENT PHARMACEUTICALS